Insiders · SNOA

Jay E Birnbaum

Director at Sonoma Pharmaceuticals, Inc. (SNOA)

Jay E Birnbaum has filed 4 insider reports with the SEC since January 2022, as director at Sonoma Pharmaceuticals, Inc. (SNOA). The latest filing, on January 2, 2026, reports grant or award at Sonoma Pharmaceuticals, Inc. (SNOA).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Jay E Birnbaum is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Sonoma Pharmaceuticals, Inc. logo
SNOA
Sonoma Pharmaceuticals, Inc.
Director$0.828Jan 2, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jay E Birnbaum with

Other insiders at the same companies

Questions about Jay E Birnbaum

What is Jay E Birnbaum's role at Sonoma Pharmaceuticals, Inc.?
Jay E Birnbaum reports to the SEC as director at Sonoma Pharmaceuticals, Inc. (SNOA), according to the latest filing on January 2, 2026.
Has Jay E Birnbaum bought or sold stock recently?
No open-market purchases or sales by Jay E Birnbaum are on file. The filings report grant or award.
How do I get alerts when Jay E Birnbaum files?
Follow Jay E Birnbaum on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jay E Birnbaum (SEC CIK 0001397470). Totals count each trade once, skipping amendments whose original is on file, from Jan 15, 2022 on. View on SEC EDGAR